Analysis of homotypic and heterotypic serum immune responses to rotavirus proteins following primary rotavirus infection by using the radioimmunoprecipitation technique
暂无分享,去创建一个
[1] R. Ward,et al. Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody. , 1992, Virology.
[2] E. Mackow,et al. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. , 1990, The Journal of infectious diseases.
[3] H. Greenberg,et al. NS35 and not vp7 is the soluble rotavirus protein which binds to target cells , 1990, Journal of Virology.
[4] R. Reves,et al. An observational study of naturally acquired immunity to rotaviral diarrhea in a cohort of 363 Egyptian children. Calculation of risk for second episodes using age-specific person-years of observation. , 1989, American journal of epidemiology.
[5] R. Shaw,et al. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4 , 1989, Journal of clinical microbiology.
[6] M. Vilar,et al. Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants , 1989, Journal of clinical microbiology.
[7] H. Greenberg,et al. Molecular determinant of rotavirus neutralization and protection. , 1989, Advances in virus research.
[8] R. Chanock,et al. Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children. , 1988, The Journal of infectious diseases.
[9] S. Plotkin,et al. Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season , 1988, The Journal of infectious diseases.
[10] R. Chanock,et al. Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus , 1988, Journal of virology.
[11] R. Ward,et al. Relative concentrations of serum neutralizing antibody to VP3 and VP7 proteins in adults infected with a human rotavirus , 1988, Journal of virology.
[12] G. Barnes,et al. Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children , 1988, Journal of clinical microbiology.
[13] M. Estes,et al. Identification of the simian rotavirus SA11 genome segment 3 product. , 1988, Virology.
[14] H. Greenberg,et al. The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[15] R. Yolken,et al. Epitope-specific immune responses to rotavirus vaccination. , 1987, Gastroenterology.
[16] R. Chanock,et al. Comparison of the amino acid sequences of the major neutralization protein of four human rotavirus serotypes. , 1987, Virology.
[17] L. Unicomb,et al. Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses , 1987, Journal of clinical microbiology.
[18] E. Norrby,et al. Serum antibody responses to individual viral polypeptides in human rotavirus infections. , 1987, The Journal of general virology.
[19] G. Both,et al. Gene cloning to study viral antigens: prospects for novel influenza and rotavirus vaccines. , 1987, Progress in veterinary microbiology and immunology.
[20] H. Greenberg,et al. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype , 1986, Journal of virology.
[21] K. Taniguchi,et al. PROTECTIVE EFFECT OF NATURALLY ACQUIRED HOMOTYPIC AND HETEROTYPIC ROTAVIRUS ANTIBODIES , 1986, The Lancet.
[22] R. Shaw,et al. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to surface proteins vp3 and vp7 , 1986, Journal of virology.
[23] P. Offit,et al. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies , 1985, Journal of virology.
[24] R. Chanock,et al. Reassortant rotaviruses as potential live rotavirus vaccine candidates , 1985, Journal of virology.
[25] R. Lerner,et al. Vaccines 85 : molecular and chemical basis of resistance to parasitic, bacterial, and viral diseases , 1985 .
[26] D. Graham,et al. Rotavirus antigens. , 1985, Advances in experimental medicine and biology.
[27] G. Zissis,et al. PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE , 1984, The Lancet.
[28] R. Bishop,et al. Cultivation of human rotaviruses in cell culture , 1984, Journal of medical virology.
[29] G. Barnes,et al. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. , 1983, The New England journal of medicine.
[30] R. Chanock,et al. Antigenic characterization of human and animal rotaviruses by immune adherence hemagglutination assay (IAHA): evidence for distinctness of IAHA and neutralization antigens , 1981, Infection and immunity.
[31] J. Chamberlain,et al. Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. , 1979, Analytical biochemistry.
[32] D. Snodgrass,et al. Passive immunity in rotaviral infections. , 1978, Journal of the American Veterinary Medical Association.
[33] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[34] J. Flores,et al. Homotypic Serum Antibody Responses to Rotavirus Proteins following Primary Infection of Young Children with Serotype 1 Rotavirus , 2022 .